Evidence map›Paper›PMID 32625259›Full record

ArticleEFSA journal. European Food Safety Authority2017

EMA and EFSA Joint Scientific Opinion on measures to reduce the need to use antimicrobial agents in animal husbandry in the European Union, and the resulting impacts on food safety (RONAFA).

EMA Committee for Medicinal Products for Veterinary Use (CVMP) and EFSA Panel on Biological Hazards (BIOHAZ), David Murphy, Antonia Ricci, Zanda Auce, J Gabriel Beechinor, Hanne Bergendahl, Rory Breathnach, Jiří Bureš, João Pedro Duarte Da Silva, Judita Hederová and 63 more

Abstract read
In one paragraph

Article in EFSA journal. European Food Safety Authority, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 169 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
169citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

169 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Novel Isolate ofAntibiotics (Basel, Switzerland) · 2025
    Article
  19. Article
  20. Review

109 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

73 authors.

EMA Committee for Medicinal Products for Veterinary Use (CVMP) and EFSA Panel on Biological Hazards (BIOHAZ)
David Murphy
Antonia Ricci
Zanda Auce
J Gabriel Beechinor
Hanne Bergendahl
Rory Breathnach
Jiří Bureš
João Pedro Duarte Da Silva
Judita Hederová
Peter Hekman
Cornelia Ibrahim
Emil Kozhuharov
Gábor Kulcsár
Eva Lander Persson
Johann M Lenhardsson
Petras Mačiulskis
Ioannis Malemis
Ljiljana Markus-Cizelj
Alia Michaelidou-Patsia
Martti Nevalainen
Paolo Pasquali
Jean-Claude Rouby
Johan Schefferlie
Wilhelm Schlumbohm
Marc Schmit
Stephen Spiteri
Stanko Srčič
Lollita Taban
Toomas Tiirats
Bruno Urbain
Ellen-Margrethe Vestergaard
Anna Wachnik-Święcicka
Jason Weeks
Barbara Zemann
Ana Allende
Declan Bolton
Marianne Chemaly
Pablo Salvador Fernandez Escamez
Rosina Girones
Lieve Herman
Kostas Koutsoumanis
Roland Lindqvist
Birgit Nørrung
Lucy Robertson
Giuseppe Ru
Moez Sanaa
Marion Simmons
Panagiotis Skandamis
Emma Snary
Niko Speybroeck
Benno Ter Kuile
Helene Wahlström
Keith Baptiste
Boudewijn Catry
Pier Sandro Cocconcelli
Robert Davies
Christian Ducrot
Christian Friis
Gregers Jungersen
Simon More
Cristina Muñoz Madero
Pascal Sanders
Marian Bos
Zoltan Kunsagi
Jordi Torren Edo
Rosella Brozzi
Denise Candiani
Beatriz Guerra
Ernesto Liebana
Pietro Stella
John Threlfall
Helen Jukes

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

EFSA and EMA have jointly reviewed measures taken in the EU to reduce the need for and use of antimicrobials in food-producing animals, and the resultant impacts on antimicrobial resistance (AMR). Reduction strategies have been implemented successfully in some Member States. Such strategies include national reduction targets, benchmarking of antimicrobial use, controls on prescribing and restrictions on use of specific critically important antimicrobials, together with improvements to animal husbandry and disease prevention and control measures. Due to the multiplicity of factors contributing to AMR, the impact of any single measure is difficult to quantify, although there is evidence of an association between reduction in antimicrobial use and reduced AMR. To minimise antimicrobial use, a multifaceted integrated approach should be implemented, adapted to local circumstances. Recommended options (non-prioritised) include: development of national strategies; harmonised systems for monitoring antimicrobial use and AMR development; establishing national targets for antimicrobial use reduction; use of on-farm health plans; increasing the responsibility of veterinarians for antimicrobial prescribing; training, education and raising public awareness; increasing the availability of rapid and reliable diagnostics; improving husbandry and management procedures for disease prevention and control; rethinking livestock production systems to reduce inherent disease risk. A limited number of studies provide robust evidence of alternatives to antimicrobials that positively influence health parameters. Possible alternatives include probiotics and prebiotics, competitive exclusion, bacteriophages, immunomodulators, organic acids and teat sealants. Development of a legislative framework that permits the use of specific products as alternatives should be considered. Further research to evaluate the potential of alternative farming systems on reducing AMR is also recommended. Animals suffering from bacterial infections should only be treated with antimicrobials based on veterinary diagnosis and prescription. Options should be reviewed to phase out most preventive use of antimicrobials and to reduce and refine metaphylaxis by applying recognised alternative measures.

Indexed as

alternativesantimicrobial consumptionantimicrobial resistancecontrol optionshusbandry

Identifiers

PMID32625259
PMCPMC7010070

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.